41058 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

Please contact the HHS Office for 

Civil Rights for more information about 

obligations and prohibitions under 

Federal civil rights laws at https://

www.hhs.gov/ocr/about-us/contact-us/ 

index.html or call 1–800–368–1019 or 

TDD 1–800–537–7697. 

F. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the Federal Awardee 

Performance and Integrity Information 

System (FAPIIS), at https://

www.fapiis.gov, before making any 

award in excess of the simplified 

acquisition threshold (currently 

$250,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a Federal awarding agency 

previously entered. IHS will consider 

any comments by the applicant, in 

addition to other information in FAPIIS, 

in making a judgment about the 

applicant’s integrity, business ethics, 

and record of performance under 

Federal awards when completing the 

review of risk posed by applicants as 

described in 45 CFR 75.205. 

As required by 45 CFR part 75, 

appendix XII, of the Uniform Guidance, 

non-Federal entities (NFEs) are required 

to disclose in FAPIIS any information 

about criminal, civil, and administrative 

proceedings, and/or affirm that there is 

no new information to provide. This 

applies to NFEs that receive Federal 

awards (currently active grants, 

cooperative agreements, and 

procurement contracts) greater than 

$10,000,000 for any period of time 

during the period of performance of an 

award/project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance and the HHS 

implementing regulations at 45 CFR part 

75, the IHS must require an NFE or an 

applicant for a Federal award to 

disclose, in a timely manner, in writing 

to the IHS or pass-through entity all 

violations of Federal criminal law 

involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 

Submission is required for all 

applicants and recipients, in writing, to 

the IHS and to the HHS Office of 

Inspector General of all information 

related to violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services, Indian Health Service, 

Division of Grants Management, ATTN: 

Paul Gettys, Acting Director, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857 (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line), Office: (301) 443–5204, 

Fax: (301) 594–0899, Email: 

Paul.Gettys@ihs.gov. 

And 

U.S. Department of Health and 

Human Services, Office of Inspector 

General, ATTN: Mandatory Grant 

Disclosures, Intake Coordinator, 330 

Independence Avenue SW, Cohen 

Building, Room 5527, Washington, DC 

20201, URL: https://oig.hhs.gov/fraud/ 

report-fraud/ (Include ‘‘Mandatory 

Grant Disclosures’’ in subject line), Fax: 

(202) 205–0604 (Include ‘‘Mandatory 

Grant Disclosures’’ in subject line) or 

Email: MandatoryGranteeDisclosures@

oig.hhs.gov. 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371 Remedies 

for noncompliance, including 

suspension or debarment (see 2 CFR 

parts 180 & 376). 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Minette C. 

Galindo, Public Health Advisor, Indian 

Health Service, Office of Clinical and 

Preventive Services, 5600 Fishers Lane, 

Mail Stop: 08N34A, Rockville, MD 

20857, Phone: (301) 443–4644, Email: 

IHSCHAP@ihs.gov. 

2. Questions on grants management 

and fiscal matters may be directed to: 

Donald Gooding, Grants Management 

Specialist, Indian Health Service, 

Division of Grants Management, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, Phone: (301) 443– 

2298, Email: Donald.Gooding@ihs.gov. 

3. Questions on systems matters may 

be directed to: Paul Gettys, Acting 

Director, Indian Health Service, 

Division of Grants Management, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, Phone: (301) 443– 

2114; or the DGM main line (301) 443– 

5204, Email: Paul.Gettys@ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Elizabeth A. Fowler, 

Acting Director, Indian Health Service. 

[FR Doc. 2021–16280 Filed 7–29–21; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Epidemiology Program for American 

Indian/Alaska Native Tribes and Urban 

Indian Communities 

Announcement Type: New and 

Competing Continuation. 

Funding Announcement Number: 

HHS–2021–IHS–EPI–0001. 

Assistance Listing (Catalog of Federal 

Domestic Assistance or CFDA) Number: 

93.231. 

Key Dates 

Application Deadline Date: 

September 1, 2021. 

Earliest Anticipated Start Date: 

September 30, 2021. 

I. Funding Opportunity Description 

Statutory Authority 

The Indian Health Service (IHS) is 

accepting applications for a cooperative 

agreement for Tribal Epidemiology 

Centers (TECs) serving American 

Indian/Alaska Native (AI/AN) Tribes 

and Urban Indian communities. This 

program is authorized under: The 

Snyder Act, 25 U.S.C. 13; the Transfer 

Act, 42 U.S.C. 2001(a); and the Indian 

Health Care Improvement Act (IHCIA), 

as amended, 25 U.S.C. 1621m. This 

program is described in the Assistance 

Listings located at https://beta.sam.gov 

(formerly known as Catalog of Federal 

Domestic Assistance) under 93.231. 

Background 

The TEC program was authorized by 

Congress in 1996 as a way to provide 

public health support to multiple Tribes 

and Urban Indian communities in each 

of the IHS Administrative Areas. The 

funding opportunity announcement is 

open to currently funded TECs. 

TECs are uniquely positioned within 

Tribes, Tribal organizations, and Urban 

Indian organizations (UIO) to conduct 

disease surveillance, research, 

prevention, and control of disease, 

injury, or disability, and to assess the 

effectiveness of AI/AN public health 

programs. Some of the existing TECs 

have already developed innovative 

strategies to monitor the health status of 

Tribes and Urban Indian communities, 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41059 

including development of Tribal health 

registries and use of sophisticated 

record linkage computer software to 

correct existing state data sets for racial 

misclassification. 

TECs provide critical support for 

activities that promote Tribal SelfGovernance and effective management 

of Tribal and Urban Indian health 

programs. Data generated locally and 

analyzed by TECs enable Tribes and 

Urban Indian communities to effectively 

plan and make decisions that best meet 

the needs of their communities. In 

addition, TECs can immediately provide 

feedback to local data systems, which 

will lead to improvements in Indian 

health data overall. 

As more Tribes choose to operate 

health programs in their communities, 

TECs ultimately will provide additional 

public health services such as disease 

control and prevention programs. Some 

existing TECs provide assistance to 

Tribal and Urban Indian communities in 

such areas as sexually transmitted 

disease (STD) control and cancer 

prevention. 

They also assist Tribes and Urban 

Indian communities to establish 

baseline data for successfully evaluating 

intervention and prevention activities. 

Sexually transmitted infections (STIs) 

remain a major public health challenge 

in the United States (U.S.) with an 

estimated 20 million new infections 

occurring each year; half of them occur 

among adolescents and young adults 

ages 15–24. Many STIs, like chlamydia 

and gonorrhea, can be asymptomatic; 

however, if left untreated, STIs can lead 

to infertility and increase the risk of 

acquiring other STIs. For pregnant 

women, there are additional risks of 

ectopic pregnancy, miscarriage, 

stillbirth, and early infant death. 

Although widespread across the U.S. 

among all populations, the STI 

epidemic disproportionately affects 

certain racial and ethnic groups, 

including AI/AN people. Such 

disparities in STI incidence are complex 

to understand but may be rooted in a 

number of social factors such as 

poverty, inadequate access to health 

care, lack of education, social 

inequality, and cultural influences. 

Recent surveillance data demonstrate 

that STI rates continue to increase in 

Indian Country. The latest surveillance 

report showed that AI/AN people have 

3.8 times the incidence rate of 

chlamydia compared with whites and a 

4.4 times higher rate of gonorrhea. For 

more information, please visit https://

www.ihs.gov/epi/includes/themes/ 

responsive2017/display_objects/ 

documents/STI/Indian_Health_

Surveillance_Report_STI_2015.pdf. AI/ 

AN people have the second highest rates 

for both chlamydia and gonorrhea 

compared to other races/ethnicities. 

Gonorrhea rates have continued to 

increase since 2011. Regional 

differences in STIs in Indian Country 

are observed. Recurrent STIs can 

increase the likelihood of human 

immunodeficiency virus (HIV) 

transmission, and gonorrhea and 

syphilis often present as co-morbid 

conditions with HIV diagnosis, 

particularly among men who have sex 

with men (MSM). 

AI/AN youth and AI/AN women, 

particularly women of reproductive age, 

have a disparate and increased STI 

burden. In addition, recent outbreaks of 

syphilis have been observed among AI/ 

AN communities, resulting in a 

dramatic increase in congenital syphilis 

cases in recent years. Some of these 

outbreaks are also connected to the use 

of injection drugs and 

methamphetamines. Particularly 

concerning is the dramatic increase in 

syphilis cases among AI/AN women and 

the rise in congenital syphilis (CS) 

cases. The CDC national STI 

surveillance report demonstrated that 

from 2014 to 2018 CS cases, among all 

races, in the U.S. increased from 462 to 

1,306 (183 percent). In 2018, AI/AN 

mothers had the highest rate of reported 

CS cases nationally. The rate of increase 

in reported CS cases among AI/AN 

mothers is higher than for any other race 

or ethnicity in the U.S. (from 13.2 cases 

per 100,000 live births in 2014 to 79.2 

in 2018). 

Untreated CS can cause miscarriage, 

stillbirth, prematurity, low birth weight, 

or death shortly after birth. The impact 

of CS depends on when a pregnant 

woman contracts syphilis and whether 

she has access to treatment for the 

infection. Up to 40 percent of babies 

born to pregnant women with untreated 

syphilis may be stillborn or die from the 

infection as a newborn. According to 

CDC data, analysis of CS cases born to 

AI/AN mothers in 2018 identified gaps 

in prenatal care and access to timely 

and appropriate treatment. 

The STI National Strategic Plan, 

released on December 17, 2020, aims to 

reverse the recent dramatic rise in STIs 

in the U.S. Please visit https://

www.hhs.gov/sites/default/files/STINational-Strategic-Plan-2021-2025.pdf 

for the most recent documents, 

outlining the following goals and 

selected objectives: 

1. Goal 1: Prevent New STIs 

a. Objective 1.1—Increase awareness 

of STIs and sexual health. 

b. Objective 1.2—Expand 

implementation of quality, 

comprehensive STI primary prevention 

activities. 

c. Objective 1.3—Increase completion 

rates of routinely recommended human 

papillomavirus (HPV) vaccination. 

d. Objective 1.4—Increase the 

capacity of public health, health care 

delivery systems, and the health 

workforce to prevent STIs. 

2. Goal 2: Improve the Health of 

People by Reducing Adverse Outcomes 

of STIs 

a. Objective 2.1—Expand high-quality 

affordable STI secondary prevention, 

including screening, care, and 

treatment, in communities and 

populations most impacted by STIs. 

b. Objective 2.2—Work to effectively 

identify, diagnose, and provide holistic 

care and treatment for people with STIs 

by increasing the capacity of public 

health, health care delivery systems, 

and the health workforce. 

3. Goal 3: Accelerate Progress in STI 

Research, Technology, and Innovation 

a. Objective 3.4—Identify, evaluate, 

and scale up best practices in STI 

prevention and treatment, including 

through translational, implementation, 

and communication science research. 

4. Goal 4: Reduce STI-Related Health 

Disparities and Health Inequities 

a. Objective 4.1—Reduce stigma and 

discrimination associated with STIs. 

b. Objective 4.2—Expand culturally 

competent and linguistically 

appropriate STI prevention, care, and 

treatment services in communities 

disproportionately impacted by STIs. 

c. Objective 4.3—Address social 

determinants of health and co-occurring 

conditions. 

5. Goal 5: Achieve Integrated, 

Coordinated Efforts that Address the STI 

Epidemic 

a. Objective 5.1—Integrate programs 

to address the syndemic of STIs, HIV, 

viral hepatitis, and substance use 

disorders. 

b. Objective 5.2—Improve quality, 

accessibility, timeliness, and use of data 

related to STIs and social determinants 

of health. 

c. Objective 5.3—Improve 

mechanisms to measure, monitor, 

evaluate, report, and disseminate 

progress toward achieving national STI 

goals. 

Furthermore, the STI National 

Strategic Plan identifies the following 

priority groups: Adolescents and young 

adults; MSM; and, pregnant women. 

The STI National Strategic Plan also 

puts emphasis on other subgroups 

including racial and ethnic minorities 

(including AI/AN people) and 

geographic focus on regions with high 

STI burden. This national plan outlines 

goals, objectives, and indicators that 


lotter on DSK11XQN23PROD with NOTICES1
41060 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

specifically focus on health disparities 

and particularly addresses disparities in 

CS among Tribal communities. 

Applicants should create their action 

plans in the context of these goals, 

objectives, and indicators. 

The TEC program will continue to 

enhance the ability of the Indian health 

system to collect and manage data more 

effectively and to better understand and 

develop the link between public health 

problems and behavior, socioeconomic 

conditions, and geography. The TEC 

program will also support Tribal and 

Urban Indian communities by providing 

technical training in public health 

practice and prevention-oriented 

research and by promoting public health 

career pathways serving AI/AN 

populations. 

Purpose 

The purpose of this IHS cooperative 

agreement is to strengthen public health 

capacity and to fund Tribes, Tribal 

organizations, and UIOs, and interTribal consortia in identifying relevant 

health status indicators and priorities to 

support Public Health interventions that 

reduce morbidity and mortality in the 

population using sound epidemiologic 

principles. Work plans submitted in 

response to this announcement must 

incorporate the applicant’s desired 

objectives and all of the required 

activities of the program’s four goal sets, 

which are combined from the seven TEC 

core functional areas as outlined in the 

Indian Health Care Improvement Act 

(IHCIA) at 25 U.S.C. 1621m(b). The 

seven core functions of the TECs are: 

(1) Collect data relating to, and 

monitor progress made toward meeting, 

each of the health status objectives of 

the Service, the Indian Tribes, Tribal 

organizations, and UIOs in the service 

area; 

(2) Evaluate existing delivery systems, 

data systems, and other systems that 

impact the improvement of Indian 

health; 

(3) Assist Indian Tribes, Tribal 

organizations, and UIOs in identifying 

highest-priority health status objectives 

and the services needed to achieve those 

objectives, based on epidemiological 

data; 

(4) Make recommendations for the 

targeting of services needed by the 

populations served; 

(5) Make recommendations to 

improve health care delivery systems for 

Indians and Urban Indians; 

(6) Provide requested technical 

assistance to Indian Tribes, Tribal 

organizations, and UIOs in the 

development of local health service 

priorities and incidence and prevalence 

rates of disease and other illness in the 

community; and 

(7) Provide disease surveillance and 

assist Indian Tribes, Tribal 

organizations, and Urban Indian 

communities to promote public health. 

The seven core functions, included in 

the four goal sets are: 

Goal Set 1: Public Health Promotion 

Collect health status data, provide 

disease surveillance and assist Tribes, 

Tribal organizations, and UIOs to 

promote public health. 

Goal Set 2: Evaluation 

Evaluate existing delivery systems, 

data systems, and other systems that 

impact the improvement of Indian 

health. 

Goal Set 3: Recommendation 

Assist Indian Tribes, Tribal 

organizations, and UIOs in identifying 

highest-priority health status objectives 

and the services needed to achieve those 

objectives, based on epidemiological 

data. Make recommendations for the 

targeting of services needed by the 

populations served. Make 

recommendations to improve health 

care delivery systems for Indians and 

Urban Indians. 

Goal Set 4: Technical Assistance 

Provide technical assistance to Indian 

Tribes, Tribal organizations, and UIOs 

in the development of local health 

service priorities and determine 

incidence and prevalence rates of 

disease and other illness in the 

community. 

Applicant objectives may include 

activities beyond the required activities 

but must address them. Additional 

activities must still fall within the seven 

core functions and the four Goal sets. 

Required activities under the core 

funding are: Community Health Profiles 

(CHP); Data collection and Disease 

Surveillance; Public Health 

Preparedness and Response; STD 

Activities; technical assistance to Indian 

Tribes, Tribal organizations, and UIOs; 

evaluate and support Area-wide 

interventions that promote severe acute 

respiratory syndrome coronavirus 2 

(SARS–CoV–2) vaccine uptake; and, 

evaluate and support Area-wide 

interventions that promote SARS–CoV– 

2 outbreak response and recovery. 

See Section I: Required, Optional, and 

Allowable Activities for full details. 

It is the intent of IHS to fund 

sufficient TECs to serve Tribes and 

Urban Indian communities in all 12 IHS 

administrative areas. 

Each TEC selected for funding will act 

under a cooperative agreement with the 

IHS. During funded activities, the TECs 

may receive Protected Health 

Information (PHI) for the purpose of 

preventing or controlling disease, 

injury, or disability, including, but not 

limited to, reporting of disease, injury, 

vital events, such as birth or death, and 

the conduct of public health 

surveillance, public health 

investigation, and public health 

interventions for the Tribal and Urban 

Indian communities that they serve. 

TECs acting under a cooperative 

agreement with IHS are public health 

authorities for which the disclosure of 

PHI by covered entities is authorized by 

the Privacy Rule, 45 CFR 164.512(b). 

Required, Optional, and Allowable 

Activities 

Goal Set 1: Collect health status data, 

provide disease surveillance, and assist 

Tribes, Tribal organizations, and UIOs 

to promote public health (Core 

Functions 1 and 7). 

Required Activities under Goal Set 1: 

(1) CHPs 

a. Develop culturally appropriate 

community health assessments 

encompassing all the Tribal and/or 

Urban Indian communities served by 

the TEC. 

b. CHPs should include information 

appropriate to allow Tribal and Urban 

Indian leaders to make informed 

decisions, prioritize health problems, 

and develop, implement, and evaluate 

their community health improvement 

plans. 

c. Provide and enact a plan that 

includes a project overview, specific 

health indicators, and means of 

dissemination for both Tribe-specific 

and regional CHPs. 

d. Participate in local, regional, and 

national committees that address public 

health priorities and, as appropriate, 

with other Federal agencies. 

e. Establish and maintain an advisory 

council that can provide overall 

program direction and guidance. The 

advisory council should include some 

members with technical expertise in 

epidemiology and public health (e.g., 

from state health departments or county 

health departments) and include 

representation from the Tribal health 

and Urban Indian health programs 

within the TECs regional area. 

f. Translate available data and/or 

results of analyses on disease incidence/ 

prevalence and determined risk factors 

into useful products, messaging, and 

outreach to effectively guide 

stakeholders’ interventions addressing 

public health priorities. 

(2) Data collection and Disease 

Surveillance 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41061 

a. Establish and maintain data sharing 

agreements and Memorandums of 

Understanding (MOU) to support data 

collection and analysis. Agreements 

may be needed with local organizations, 

Tribal governments, state authorities, 

and Federal agencies. 

b. Provide disease surveillance and 

assist Indian Tribes, Tribal 

organizations, and UIOs to promote 

public health. 

Optional Activities with Budget 

Support under Goal Set 1: 

(1) IHS-funded UIOs Technical 

Assistance 

These activities are eligible for a 

supplemental budget of up to $100,000 

per award. 

The grantee will support 41 IHSfunded UIOs located in 22 states 

through the following activities: 

a. Providing training and technical 

assistance on planning, conducting, and 

implementing community health needs 

assessment; 

b. developing new and updating 

existing CHPs; and 

c. providing ongoing training and 

tutorials on how to interpret data, such 

as the Census and American 

Community Survey data. 

These activities have additional 

reporting requirements including 

quarterly progress reports that are due 

within 30 days after the budget period 

ends. These reports must include a brief 

comparison of actual accomplishments 

to the goals established for the period, 

a summary of progress to date or, if 

applicable, provide sound justification 

for the lack of progress, and other 

pertinent information as required. 

(2) Group A HIV/STI Activities 

These activities are eligible for a 

supplemental budget of up to $100,000 

per awardee. 

Activities under this supplement are 

organized under the operational 

strategies of the Ending the HIV 

Epidemic: A Plan for America initiative 

(EHE). 

TEC sites serving areas that do not 

include the EHE Phase One priority 

Geographic area(s) and Location(s) are 

eligible to apply for this supplemental 

funding. For a list of Phase One priority 

Geographic Areas and Locations, please 

visit https://www.hiv.gov/federalresponse/ending-the-hiv-epidemic/ 

jurisdictions/phase-one. 

Coordination Operational Strategy 

a. Grantees will send at least one 

representative to the annual HIV 

Coordination meeting, scheduled in 

September of each year to coincide with 

the U.S. Conference on HIV/acquired 

Immunodeficiency syndrome (AIDS). 

The budget should include travel and 

associated costs for participation. 

b. Grantees will participate in the IHS 

National AI/AN STI Prevention 

workgroup. 

Diagnosis Operational Strategy 

c. The TECs will provide technical 

assistance and/or disease surveillance 

support to Tribal and Urban 

communities by developing analytical 

reports to examine the burden of HIV 

and other relevant comorbidities such as 

STIs and hepatitis C virus (HCV) in 

Tribal and Urban communities. 

Treatment Operational Strategy 

d. The TECs will provide support to 

Tribal and Urban communities in the 

development of enhanced activities and 

expanded capacity to better identify AI/ 

AN people who are not in care, 

including those who were never linked 

to care following an HIV, STI, or HCV 

diagnosis and those who have fallen out 

of care. 

Respond Operational Strategy 

e. Respond rapidly to detect and 

characterize growing HIV, STI, or HCV 

clusters and prevent new infections. 

TECs will provide technical assistance 

and/or direct support to Tribal and 

Urban communities on the following 

activities: 

i. Develop or accelerate the 

refinement of HIV, STI, and HCV 

community plans that are customized 

for AI/AN communities. Extensive 

community engagement in this process 

will help ensure that communityspecific social norms and unique 

epidemic attributes are addressed. 

ii. Develop collaborative partnerships 

among Tribal, state, and local health 

departments, the clinical community, 

and community-based organizations to 

expand and routinize HIV diagnosis, 

treatment, prevention, and response. 

(3) Group B HIV/STI Activities 

These activities are eligible for a 

supplemental budget of up to $250,000 

per awardee. 

Applicants may either request Group 

A or Group B activities based on their 

geographic service area. Applicants 

should not apply for both Group A and 

Group B activities. 

Activities under this supplement are 

organized under the operational 

strategies of the EHE. 

TEC sites serving areas that do 

include the EHE Phase One priority 

Geographic area(s) and Location(s) are 

eligible to apply for this supplemental 

funding. 

For a list of Phase One priority 

Geographic Areas and Locations, please 

visit https://www.hiv.gov/federalresponse/ending-the-hiv-epidemic/ 

jurisdictions/phase-one. 

Applications for Group B HIV 

Activities must include the following 

activities. 

Coordination Operational Strategy 

a. Grantees will send at least one 

representative to the annual HIV 

Coordination meeting scheduled in 

September of each year to coincide with 

the U.S. Conference on AIDS. The 

budget should include travel and 

associated costs for participation. 

b. Grantees will participate in the IHS 

National AI/AN STI Prevention 

workgroup. 

Diagnosis Operational Strategy 

c. The TECs will provide technical 

assistance and/or disease surveillance 

support to communities by developing 

analytical reports to examine the burden 

of HIV and other relevant comorbidities 

such as STIs and HCV in Tribal 

communities. 

Treatment Operational Strategy 

d. The TECs will provide support to 

communities in the development of 

enhanced activities and expanded 

capacity to better identify people who 

are not in care, including those who 

were never linked to care following an 

HIV, STI, or HCV diagnosis and those 

who have fallen out of care. 

Respond Operational Strategy 

e. Respond rapidly to detect and 

characterize growing HIV, STI, or HCV 

clusters and prevent new infections. 

TECs will provide technical assistance 

and/or direct support to communities 

on the following activities: 

i. Develop or accelerate the 

development and/or refinement of 

community plans that are customized 

for AI/AN communities. Extensive 

community engagement in this process 

will help ensure that communityspecific social norms and unique 

epidemic attributes are addressed. 

ii. Develop collaborative partnerships 

among Tribal, state, and local health 

departments, the clinical community, 

and community-based organizations to 

expand and routinize HIV diagnosis, 

treatment, prevention, and response. 

Further Activities under this 

Supplement 

Applications are required to address 

the above activities, and must propose 

activities addressing at least two of the 

additional operational strategies below. 

Diagnosis Operational Strategy 

a. Diagnose all people with HIV, STIs, 

and HCV as early as possible after 

infection and connect them to 

immediate treatment. The TECs will 

provide technical assistance and/or 

direct support to AI/AN communities 

on the following activities: 

i. Implementing HIV testing 

recommendations through the rapid 

replication of proven or innovative HIV 

screening models; 

ii. Developing and implementing 

innovative testing and health care 


lotter on DSK11XQN23PROD with NOTICES1
41062 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

engagement strategies focused on 

meeting the needs of groups at higher 

risk, including MSM, transgender 

individuals, high-risk heterosexuals, 

and persons who inject drugs. 

Protection Operational Strategy 

b. Protect people at risk for HIV using 

potent and proven prevention 

interventions, including Pre-Exposure 

Prophylaxis (PrEP), a medication that 

can prevent new HIV infections. The 

TECs will provide technical assistance 

and/or direct support to communities 

on the following activities: 

i. Support efforts to increase the 

awareness of, access to, and utilization 

of PrEP among identified populations; 

ii. Support efforts to incentivize 

providers and community-based health 

care organizations to integrate HIV 

testing, linkage, and referral to care, and 

linkage or referral to medical prevention 

(i.e., PrEP) services into primary care 

services, particularly for their higherrisk patients; 

iii. Raise awareness about the 

prevention benefits of ‘‘Treatment as 

Prevention’’ (TasP) and ‘‘Undetectable = 

Untransmittable’’ (U=U) among 

providers, people living with and at risk 

for HIV, and the general population; 

iv. As an entry point to recovery 

services and overdose and infection 

prevention, support the development, 

expansion, implementation, and 

evaluation of harm-reduction services 

for people who inject drugs. 

v. Evaluate the local acceptability and 

opportunities for establishing or 

increasing syringe services programs 

(SSPs) including: Linkage to substance 

use disorder treatment; access to and 

disposal of sterile syringes and injection 

equipment; and vaccination, testing, 

and linkage to care and treatment for 

infectious diseases. 

vi. Promote early identification of 

individuals with recurrent STI events 

with focus on chlamydia, gonorrhea, 

and syphilis through analysis of clinical 

or other locally available data. 

vii. Promote linkage to care including 

PrEP or other appropriate services to aid 

the prevention of HIV and other 

infectious disease transmission, 

especially for those diagnosed with 

STIs. 

viii. Promote and support Expedited 

Partner Therapy (EPT) for individuals 

diagnosed with chlamydia and 

gonorrhea to control transmission. 

ix. Promote enhanced STI screening 

among youth and MSM and engage 

providers in adopting best practices, 

such as obtaining a thorough sexual 

history and promoting an adolescentfriendly clinic environment. 

Respond Operational Strategy 

c. Respond rapidly to detect and 

characterize growing HIV, STI, or Viral 

hepatitis clusters and prevent new 

infections. The TECs will provide 

technical assistance and/or public 

health surveillance support to 

communities on the following activities: 

i. Establish and support boots-on-theground public health workforce capacity 

that is culturally competent and 

committed to ensuring implementation 

of community-based HIV, STI, and/or 

Viral hepatitis control plans, including 

facilitating and troubleshooting 

collaborative community-wide disease 

control efforts; 

ii. Develop or expand the capacity to 

detect and respond to all established or 

emerging HIV, STI, and/or Viral 

hepatitis clusters to reduce disease 

transmission. 

Allowable Activities Under Goal Set 

1: 

(1) Enhance or develop disease 

surveillance systems. Surveillance 

systems can address infectious and 

chronic diseases, record linkage studies 

to improve existing surveillance 

systems, suicide data tracking, regional 

health registries, influenza surveillance, 

among others. 

(2) Carry out at least one new disease 

surveillance activity per cycle, complete 

with evaluation and the use of 

measurable outcomes. 

Goal Set 2: Evaluate existing delivery 

systems, data systems, and other 

systems that impact the improvement of 

Indian health (Core Function 2). 

Required Activities under Goal Set 2: 

None required. 

Optional Activities with Budget 

Support under Goal Set 2: 

(1) Annual Cancer Survivorship 

Leadership Training 

This activity is eligible for a 

supplemental budget of up to $85,000 

per awardee. One award is anticipated. 

This activity supports the CDC 

National Center for Chronic Disease 

Prevention and Health Promotion 

activity Annual Cancer Survivorship 

Leadership Training. Grantee will 

organize and implement at least two, 

three-day cancer support leadership 

trainings for 15–25 AI/AN participants, 

nationally. The training will be 

designed to give participants a unique 

opportunity to work together in a safe, 

supportive environment to learn and 

practice skills to help people affected by 

cancer in their communities. The 

training will be based on the model, A 

Gathering of Cancer Support, using the 

Gathering of Native Americans (GONA) 

teaching methods. 

Outcome: 

Participants will show change in 

knowledge/understanding of the below 

elements: 

Wellness from a Native American 

Perspective 

a. Using a group discussion method 

such as Rez Cafe ́, identify two AI/AN 

core values that support wellness and 

healing. 

b. Using a group discussion method 

such as Rez Cafe ́, identify two AI/AN 

core values to draw from to help 

facilitate a support group. 

Cancer 101 

c. Describe two ways to take personal 

action to reduce cancer risk 

Exploring Emotional Peer Support 

Skills and How to Start Up Cancer 

Support in Your Community. 

d. Determine best role for self in 

setting up cancer support. 

e. Identify at least two steps for 

starting up cancer support in your 

community. 

(2) Tribal Public Health Departments 

This activity is eligible for a 

supplemental budget of up to $150,000 

per awardee. Six awards are anticipated. 

a. Conduct Ecological Assessments on 

Tribal public health programs and 

services in your Area. 

b. Develop plans with specific Tribes 

on strengthening Tribal public health 

programs and services. 

c. Support the establishment and/or 

expansion of one or more Tribal public 

health department(s) in your Area. 

Allowable Activities Under Goal Set 

2: 

(1) Evaluate sufficiency of IHS 

electronic health record data to 

determine AI/AN health status, to create 

seamless data linkages, and to meet the 

health information needs for Tribes and 

Tribal programs. This should include an 

assessment of the ability for the health 

information systems to meet those 

needs, create seamless data linkages, 

and meet data access needs for Tribes 

and Tribal organizations. 

Goal Set 3: Assist Indian Tribes, 

Tribal organizations, and UIOs in 

identifying highest-priority health status 

objectives and the services needed to 

achieve those objectives, based on 

epidemiological data. 

Make recommendations for the 

targeting of services needed by the 

populations served. 

Make recommendations to improve 

health care delivery systems for Indians 

and Urban Indians (Core Functions 3, 4, 

and 5). 

Required Activities Under Goal Set 3: 

(1) Public Health Preparedness and 

Response 

a. Strengthen Tribally-focused 

surveillance systems and data. 

b. Conduct outbreak investigations 

and response. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41063 

c. Lead community assessments for 

disaster preparedness, response, and 

recovery. 

d. Develop response plans for major 

public health emergencies. 

e. Lead, coordinate, or participate in 

Federal, Tribal, state, or local emergency 

response exercises and activities. 

f. Promote and facilitate planning and 

response activities among Tribes. 

g. Build partnerships among 

government agencies, Tribes, and other 

organizations to advance emergency 

preparedness in Indian country. 

(2) STD Activities 

The grantees will conduct activities in 

this announcement to support the above 

STI National Strategic Plan goals and 

indicators pertaining to chlamydia, 

gonorrhea, Primary and Secondary 

Syphilis and congenital syphilis. While 

the STI National Strategic Plan includes 

HPV as an additional focus, applicants 

should not emphasize HPV in their 

application. However, HPV-related 

activities can be incorporated into 

project plans as a secondary focus if 

desired, as appropriate and if relevant or 

complementary to primary work. 

a. Community Profiles 

In year 1 of award, the grantees will 

develop an assessment of the overall 

burden of the following STIs: 

Chlamydia, gonorrhea, primary and 

secondary syphilis, and congenital 

syphilis within the communities they 

serve. 

To support the profile, the grantees 

will analyze current, existing data or 

generate their own data related to STI 

burden with particular emphasis on 

priority groups listed above and any 

other priority groups identified during 

the assessment phase. When analyzing 

existing data, grantees will ensure 

analyses are novel and not duplicative 

of analytic approaches or products 

available from other sources. Data may 

include publically available data, 

surveillance data, clinical data, 

qualitative data, or other relevant health 

data source. Applicants should 

prioritize data that describe STI burden 

in Tribal communities within their 

jurisdiction, such as through 

partnerships with public health 

authorities at the Tribal, local or state 

level. Although historic data may be 

reviewed, analysis must incorporate 

data on the burden of STIs generated 

within the last 5 years. The applicants 

are encouraged to create assessments 

that examine STI burden at different 

Tribal communities and report those 

results accordingly; regional or IHS Area 

level results or national level results can 

be used for comparison purposes. 

Special focus should be on indicators 

and priority areas outlined in the STI 

National Strategic Plan. 

The assessment will serve as a living 

document and will be updated 

minimally on year 3 and year 5 of the 

award. 

During years, 2–5 of the award the 

grantees should: (1) Work to obtain 

information from community members 

and Tribal leaders on defining gaps and 

opportunities to further improve STI 

prevention and care and (2) conduct 

relevant interventions to improve STI 

prevention and care services. The 

grantees will create a report describing 

the findings from their community 

engagement and outlining any relevant 

feasibility, gaps, and opportunities 

identified in the interventions 

conducted. Interventions can be 

expanded to more communities 

depending on results, feasibility, and 

acceptability. 

b. Communication of findings 

At the end of year one grantees will 

create a report outlining analytic 

findings of the community profile 

assessments and also create and include 

a strategic plan and road map on how 

to address STI burden within the 

supported AI/AN communities. 

Applicants are encouraged to align their 

strategic approach with the vision and 

goals of the National STI Strategic Plan 

and implementing the objectives and 

strategies most relevant to their role and 

communities. In addition, applicants 

should use available data to identify 

where their resources will have the most 

impact and to determine indicators and 

targets best suited to measure their 

progress towards selected goals. The 

applicant strategic plan is meant to 

serve as a living document and be 

updated based on inputs from 

supported communities and lessons 

learned as the work progresses. Please 

visit https://www.hhs.gov/sites/default/ 

files/STI-National-Strategic-Plan-2021- 

2025.pdf for further background. 

The grantees will create or adapt 

communication materials for 

appropriate audiences (community 

members, Tribal leaders, health care 

providers) and convene meetings to 

share findings with community 

members and other stakeholders such as 

Tribal leadership, medical providers, 

public health partners, etc. 

The grantees will work with selected 

communities to create detailed strategic 

plans on how to improve STI prevention 

with specific focus on aligning to any 

STI National Strategic plan goals, 

objectives, and indicators and convene 

a coalition with diverse partners 

(community members, public health 

professionals, trainers, health care 

providers and others). Communities can 

self-identify or be selected in 

collaboration with the applicant based 

on available epidemiologic evidence. 

Each grantee will work with at least two 

communities. 

c. Meetings 

Grantees will meet with IHS Division 

of Epidemiology and Disease Prevention 

(DEDP) staff quarterly to discuss activity 

progress and garner technical assistance. 

Grantees will regularly participate in 

IHS National STI program workgroup 

meetings. Each grantee is requested to 

present once a year on their activities 

relating to this announcement at these 

meetings. 

Grantees are encouraged to share 

knowledge gained by presenting 

findings at Tribal meetings, regional 

meetings and/or publishing in peerreviewed journals. 

Grantees will attend one national STIfocused meeting such as the National 

Coalition of STD Directors annual 

meeting or the National STD conference 

and are strongly encouraged to submit 

abstracts for presentations. When such 

meetings are held in person, applicant’s 

budget should include travel costs for 

up to three staff to attend. 

d. Outcomes 

The applicant will provide evidence 

of direct dissemination of assessment 

results to Tribal communities including 

Tribal leadership. 

Dissemination could include 

meetings, online reports (and number of 

views), media releases, and newsletters. 

Optional Activities with Budget 

Support under Goal Set 3: 

(1) Targeted STD Activities 

This activity is eligible for a 

supplemental budget of up to $150,000 

per awardee. Six awards are anticipated. 

To qualify for targeted STD activities, 

the applicant must demonstrate an 

increased incidence of congenital 

syphilis or syphilis among women of 

reproductive age within their 

jurisdiction. 

The STI National Strategic Plan 

specifically outlines a focus on 

congenital syphilis (CS) in Tribal 

communities and includes a disparity 

indicator to reduce CS rate among AI/ 

AN people/communities. 

In order to achieve a reduction in CS 

rates among AI/AN people, a 

comprehensive approach to reduce 

syphilis rates among women of 

reproductive age is necessary. Grantees 

will conduct activities in one or more of 

the following domains with the goal to 

address the STI Disparity Indicator 

focusing on the reduction of CS cases 

among AI/AN people. Applicants can 

propose additional relevant work to 

address CS among their communities. 


lotter on DSK11XQN23PROD with NOTICES1
41064 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

Activities are intended to complement 

and expand from required STD 

activities and develop a logic model 

specific to this activity apart from the 

program-wide logic model. 

a. Linkage to prenatal care 

Applicants will address gaps in 

prenatal care that contribute to late 

maternal syphilis screening and 

treatment. Applicants should prioritize 

hard to reach populations, including, 

but not limited to, persons experiencing 

homelessness and Persons Who Inject 

Drugs (PWID), and design interventions 

to link these populations to care. 

Applicants will determine whether 

third trimester screening is occurring 

within their jurisdictions and evaluate 

its ability to (a) avert cases before birth; 

and (b) detect and treat additional CS 

cases. Applicants may partner with 

health care providers to test different 

scalable interventions; for example, the 

feasibility and impact of Electronic 

Health Record reminders and/or 

screening at delivery. 

b. Surveillance 

Applicants will design activities to 

address surveillance gaps to capture and 

accurately report syphilis cases among 

AI/AN women (particularly women of 

reproductive age) and understand risk 

factors associated with transmission. 

c. Outbreak response plans and 

trainings 

Applicants will assess gaps in current 

practices to respond to syphilis 

outbreaks within their jurisdiction. 

Applicants will develop comprehensive 

syphilis outbreak response plans that 

incorporate and enhance health 

education and training for providers and 

disease investigators serving the 

community. Feasibility of response 

plans will be assessed with Tribes and 

Tribal leadership within their 

jurisdiction. Applicants can include 

other STIs in outbreak response plans. 

Applicants will assess training needs 

and identify providers/Disease 

Intervention Specialists in need of 

training and arrange or develop 

resources. Applicants will connect with 

existing resources like the STD 

Prevention Training Centers to create 

trainings for providers in their 

community that are tailored to local 

needs and that are culturally 

appropriate. Applicants may find more 

information on the STD Prevention 

Training Centers at https://

www.nnptc.org/. 

d. Screening in alternative locations 

Applicants will create an inventory of 

any screening currently conducted in 

alternative locations within their 

jurisdiction and pilot novel screening 

programs for syphilis (but also 

including other STIs) that may reach 

heterosexual populations. Applicants 

will evaluate the effectiveness of such 

interventions at case-finding and 

treatment. This could include jails, 

inpatient or Emergency Department 

settings, and substance abuse treatment 

centers. 

e. Communication of findings 

The grantee will create a report 

outlining findings and develop a local 

strategic plan and road map on how to 

address CS and syphilis burden within 

the supported AI/AN communities. This 

plan will differentiate from the work 

conducted under Part A activities. 

The grantees will create or adapt 

communication materials for 

appropriate audiences (community 

members, Tribal leaders, health care 

providers) and convene meetings to 

share findings with community 

members and other stakeholders such as 

Tribal leadership, medical providers, 

public health partners, etc. 

Grantee will convene a coalition with 

diverse partners (community members, 

public health professionals, trainers, 

health care providers and others) to 

create concrete action steps to target CS 

in their jurisdiction and to inform 

further adaptation of the local strategic 

plan. 

f. Meetings and Reporting 

Grantees will meet with IHS DEDP 

staff quarterly to discuss activity 

progress and garner technical assistance. 

Grantees will provide reports two 

times a year summarizing progress 

towards outcomes in Logic Model. 

Grantees will participate in any IHS 

National STI program workgroup 

meetings focusing on CS and share their 

activities with other participants. 

Grantees will present on their CS 

activities minimally once per year. 

Grantees are encouraged to share 

knowledge gained by presenting 

findings at Tribal, regional, or national 

meetings and/or publishing in peerreviewed journals. 

g. Outcomes 

Demonstrated improvement in 

capturing of syphilis cases among 

women of reproductive age and 

ascertainment of CS cases. 

Demonstrated improvement of linkage 

to care and screening for syphilis with 

particular emphasis on hard to reach 

populations, including, but not limited 

to, persons experiencing homelessness 

and PWID. 

The grantees will provide evidence of 

direct dissemination of findings to 

Tribal communities including Tribal 

leadership. Dissemination could include 

meetings, online reports (and number of 

views), media releases, and newsletters. 

Allowable Activities Under Goal Set 

3: 

(1) Public Health Response 

Grantees may conduct further 

activities not addressed above 

including: 

a. Infectious Disease control. 

b. Outbreak Response. 

c. Assess and support Environmental 

Health emerging needs of local 

communities. 

Goal Set 4: Provide technical 

assistance to Indian Tribes, Tribal 

organizations, and UIOs in the 

development of local health service 

priorities and to determine incidence 

and prevalence rates of disease and 

other illness in the community (Core 

Function 6). 

Required Activities Under Goal Set 4: 

(1) Provide culturally appropriate 

training and technical support based on 

the needs of Indian Tribes, Tribal 

organizations, and UIOs served. Topics 

may include but are not limited to 

program evaluation, data analysis, data 

quality, survey design and 

administration, program planning, 

community health assessment, and 

outbreak response. 

a. Implement and evaluate at least one 

public health intervention (conducted 

by grantee or by supported community) 

to promote health or address disparities 

in AI/AN communities. 

(2) Evaluate and support Area-wide 

interventions that promote SARS–CoV– 

2 vaccine uptake. Assess community 

attitudes/knowledge/beliefs around 

vaccine availability, vaccine coverage, 

and uptake among AI/AN populations 

and the IHS/Tribal/Urban health care 

workforce. Address sufficiency and/or 

gaps regarding vaccine messaging and 

public communication campaigns and 

develop implementation strategies to 

maximize vaccine coverage among AI/ 

AN communities. 

This requirement will have a separate 

budget of $250,000 per TEC. 

a. Explain how the TEC will develop, 

maintain and strengthen relationships 

with other public health authorities 

(e.g., Tribal, county, state) in order to 

facilitate Public Health assessment, 

response, communications and 

dissemination relevant to vaccine 

implementation to enhance uptake and 

overall coverage. 

b. The TEC will develop a 

comprehensive needs assessment 

relevant to the ongoing SARS–CoV–2 

vaccine implementation efforts within 

their relevant IHS Area. 

i. Assessment should include 

implementation gaps and opportunities 

for improvement in local vaccination 

activities. 

ii. Based on needs assessment 

findings, develop and implement 

intervention strategies to address gaps 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41065 

and enhance opportunities related to 

improving local vaccine 

implementation, uptake, and 

communications. 

iii. Perform ongoing evaluation of 

activities to determine effectiveness and 

impacts and to inform future efforts. 

c. Perform an assessment of existing 

vaccination capacity, implementation, 

and uptake for years 1–3 of this funding 

cycle. Plans for years 4–5 should use 

this assessment to continue, adapt, and 

evaluate changes in local conditions and 

respond to ongoing vaccination needs 

and goals. 

(3) Evaluate and support Area-wide 

interventions that promote coronavirus 

disease 2019 (COVID–19) pandemic 

response, mitigation, and recovery. 

This requirement should have a 

budget of at least $1,000,000 per site. 

(a) Explain how the TEC will develop, 

maintain, and strengthen relationships 

with other public health authorities 

(e.g., Tribal, county, state) in order to 

facilitate collaborative pandemic 

outbreak response activities at the local 

and regional level. 

(b) These COVID funds are to meet 

immediate needs in the response, 

mitigation, and recovery from the 

COVID–19 pandemic. Plans for 

activities should be explicitly tied to 

measurable pandemic response, 

mitigation, and recovery outcomes. 

Optional Activities with Budget 

Support under Goal Set 4 

(1) SASP/DVP/FHC Technical 

Assistance 

This activity is eligible for a 

supplemental budget of up to $265,000 

per awardee. 

Twelve awards are anticipated. 

Objective: To provide Technical 

Assistance (TA) to the Substance Abuse 

and Suicide Prevention (SASP), 

Domestic Violence Prevention (DVP), 

and Forensic Health Care (FHC) projects 

funded within their regional area. 

Technical Assistance (TA) should apply 

to Tribes, Tribal organizations, UIOs, 

and Federal facilities that receive grants 

from IHS Behavioral Health. TA should 

assist projects in meeting required 

reporting activities. 

a. Cross-Site/Group TA 

i. Representatives from TECs 

participate in monthly calls with IHS 

Division of Behavioral Health (DBH) 

program staff. 

ii. The TECs will facilitate or 

participate in scheduled Area Project 

Officer (APO) monthly conference calls/ 

webinars to include all grantees within 

their respective IHS Area. 

iii. Organize and facilitate quarterly 

webinars related to the expectations and 

required activities of the SASP, DVP 

and FHC grant programs. 

iv. Provide at least one opportunity 

per year for individual grantees to meet 

with local TEC annually at regional or 

national meeting forum (for example, 

regional behavioral health conferences). 

v. Coordinate in-person, virtual, or 

teleconference peer-to-peer support 

opportunities for grantees. 

b. Individualized Training and 

Technical Assistance (TTA) 

i. Engage in regular communication 

with grantee project directors and/or 

project coordinators, providing 

individualized TTA to SASP/DVP/FHC 

grantees based on the needs of 

individual grant community to meet the 

expectations and required activities of 

the grant program. 

ii. Provide monthly, individual virtual 

site visits. 

iii. Document individual one-on-one 

meetings that occurred at regional or 

national meetings, such as regional 

behavioral health conferences. 

iv. Develop an individualized data 

collection tracker to assist grantees with 

local data collection. 

v. TECs will work with grantees to 

establish baseline data related to the 

SASP/DVP/FHC funded projects, DBH 

Alcohol and Substance Abuse (ASA) 

Government Performance and Results 

Act (GPRA) measures and other IHS 

Strategic Plan Goals. 

vi. Technical assistance provided by 

TECs in this cooperative agreement are 

limited to efforts that support grantee 

submission of the required DBH annual 

progress report (APR) and granteespecific interventions outlined in the 

applicant project narrative. 

vii. TECs should outline available 

resources and technology, including 

software technology for project data 

analysis and management. TECs may 

use resources available to them to 

enhance TA support including software, 

maintenance, and storage capabilities. 

However, it is recommended that these 

activities include an established 

agreement between the TEC and the 

grantee. 

c. Development of Resources 

i. Support grantee development of 

publications and/or presentation for use 

in their program. 

ii. Provide subject matter expertise, 

tools, and resources to enhance grantee 

development of culturally competent, 

community-based methods for local 

evaluation and data collection plans. 

iii. Create individualized training 

plans for use with grantees. 

iv. Support development of MOUs 

related to project needs (e.g., provide 

templates for establishing data 

collection plans and data sharing 

agreements, partnerships, and/or 

services). 

v. Develop TTA material including 

public health messages, and aid in 

public health messaging practice guides 

to assist grantees in developing 

documents identified as grant required 

activities. 

(2) Zero Alcohol and Substance Abuse 

(ASA) Suicide Initiative Technical 

Assistance 

This activity is eligible for a 

supplemental budget of up to $125,000 

per awardee. 

One award is anticipated. 

Objective: To provide technical 

assistance that supports the data 

collection and data analysis 

requirements of local projects funded 

under the two IHS Alcohol and 

Substance Abuse Pilot Project 

Initiatives; the Community Opioid 

Intervention Pilot Project (COIPP) and 

the Youth Regional Treatment Center 

(YRTC) Aftercare Pilot Project. 

Technical assistance should apply to 

Tribes, Tribal organizations, UIOs and 

Federal facilities that receive grants 

from IHS Behavioral Health. 

a. Data Collection, Analysis, and 

Reporting 

i. Support local grantee efforts to 

develop data plans that will support 

grant objectives, project activities and 

evaluation efforts. Each grantee was 

highly recommended to develop a logic/ 

model or theory of change as part of 

their project description. 

1. Technical assistance provided by 

TECs in this cooperative agreement 

shall support data collection, analysis, 

and reporting. Data shall be coordinated 

and submitted with local grantee 

evaluation efforts and required annual 

progress reports. 

2. Work with grantees to establish 

baseline data related to pilot project. 

3. Work with grantees to establish a 

local data collection plan, including 

project data collection tracker related to 

proposed activities and evaluation 

efforts. Data will include a compilation 

of quantitative and qualitative data that 

addresses the project impact including 

outcomes such as performance measures 

related to evaluation outcomes and 

intended results. 

4. TECs will assist grantees to include 

and prioritize the collection and 

reporting of DBH ASA GPRA measures 

and other IHS Strategic Plan Goals. 

ii. Technical assistance provided by 

TECs in this cooperative agreement 

shall support grantee submission of the 

required DBH APR. 

iii. TECs should outline available 

resources and technology, including 

software technology for project data 

analysis and management. TECs may 

use resources available to them to 

enhance TA support including software, 


lotter on DSK11XQN23PROD with NOTICES1
41066 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

maintenance, and storage capabilities. 

However, it is recommended that these 

activities include an established 

agreement between the TEC and the 

grantee. 

b. Individualized TTA 

i. Engage in regular communication 

with grantee project directors and/or 

project coordinators, providing 

individualized TTA based on the needs 

of individual pilot project and Tribal 

community to meet the expectations 

and required activities of the grant 

program. 

ii. Provide monthly, individual virtual 

site visits. 

iii. Document individual one-on-one 

meetings that occurred at regional or 

national meetings, such as regional 

behavioral health conferences. 

c. Development of Resources 

i. Support grantee development of 

publications and/or presentation for use 

in their program. 

ii. Provide subject matter expertise, 

tools, and resources to enhance grantee 

development of culturally competent, 

community-based methods for local 

evaluation and data collection plans. 

iii. Support development of MOUs 

related to project needs (e.g., provide 

templates for establishing data 

collection plans and data sharing 

agreements, partnerships, and/or 

services). 

(3) Diabetes Activities 

This activity is eligible for a 

supplemental budget of up to $100,000 

per awardee. 

One award is anticipated. 

a. Provide data technical assistance to 

the Urban Indian Health Organization 

(UIHO) Special Diabetes Program for 

Indians (SDPI) grantees to support their 

diabetes prevention and treatment 

services. 

b. Develop the annual Urban Diabetes 

Care and Outcomes Summary Report, 

which provides an overview of the 

UIHO data submitted into the IHS 

Diabetes Care and Outcomes Audit. 

These reports provide data on the 

diabetes care provided as well as the 

outcomes achieved in the UIHO patient 

population, including identifying areas 

for improvement. 

Allowable Activities under Goal Set 4: 

None additional. 

Pre-Conference Grant Requirements 

The awardee is required to comply 

with the ‘‘HHS Policy on Promoting 

Efficient Spending: Use of Appropriated 

Funds for Conferences and Meeting 

Space, Food, Promotional Items, and 

Printing and Publications,’’ dated 

January 23, 2015 (Policy), as applicable 

to conferences funded by grants and 

cooperative agreements. The Policy is 

available at https://www.hhs.gov/grants/ 

contracts/contract-policies-regulations/ 

efficient-spending/index.html?

language=es. 

The awardee is required to: 

Provide a separate detailed budget 

justification and narrative for each 

conference anticipated. The cost 

categories to be addressed are as 

follows: (1) Contract/Planner, (2) 

Meeting Space/Venue, (3) Registration 

website, (4) Audio Visual, (5) Speakers 

Fees, (6) Non-Federal Attendee Travel, 

(7) Registration Fees, and (8) Other 

(explain in detail and cost breakdown). 

For additional questions please contact 

Lisa C. Neel at (301) 443–4305 or email 

at lisa.neel@ihs.gov. 

II. Award Information 

Funding Instrument—Cooperative 

Agreement 

Estimated Funds Available 

The total funding identified for fiscal 

year (FY) 2021 is approximately 

$30,750,000. Individual award amounts 

for the first budget year are anticipated 

to be between $1,070,000 and 

$3,000,000. The funding available for 

competing and subsequent continuation 

awards issued under this announcement 

is subject to the availability of 

appropriations and budgetary priorities 

of the Agency. The IHS is under no 

obligation to make awards that are 

selected for funding under this 

announcement. 

Funding for this award will be 

provided through: The IHS Office of 

Public Health Support, the IHS Office of 

Urban Indian Health Programs, the IHS 

Office of Clinical and Preventive 

Services, National Human 

Immunodeficiency Virus (HIV) & Viral 

Hepatitis C (HCV) Program in 

partnership with the U.S. Department of 

Health and Human Services (HHS) 

Minority HIV/AIDS Fund (MHAF), the 

Centers for Disease Control and 

Prevention’s (CDC) National Center for 

Chronic Disease Prevention and Health 

Promotion, and the National Institutes 

of Health’s (NIH) National Institute on 

Minority Health and Health Disparities 

(NIMHD). The authorities for CDC and 

NIH funding will be exercised through 

an Intra-Departmental Delegation of 

Authority (IDDA) with IHS. The 

administration will be carried out 

through an Intra-agency Agreement 

(IAA) between CDC, NIH, and IHS. 

Portions of this award will be funded by 

the Office of the Assistant Secretary for 

Health, HHS, as authorized under the 

statutory earmark for minority AIDS 

prevention and treatment activities, and 

are to be carried out pursuant to Title 

III of the Public Service Act. The 

funding is being made available through 

an IDDA to award specific funding for 

fiscal year (FY) 2021. 

Anticipated Number of Awards 

Approximately 12 awards will be 

issued under this program 

announcement. 

Period of Performance 

The period of performance is for five 

years. 

Cooperative Agreement 

Cooperative agreements awarded by 

the HHS are administered under the 

same policies as a grant. However, the 

funding agency (IHS) is anticipated to 

have substantial programmatic 

involvement in the project during the 

entire award segment. Below is a 

detailed description of the level of 

involvement required for the IHS. 

Substantial Agency Involvement 

Description for Cooperative Agreement 

(1) Provide funded TECs with ongoing 

consultation and technical assistance to 

plan, implement, and evaluate each 

component as described under 

Recipient Activities. Consultation and 

technical assistance may include, but 

not be limited to, the following areas: 

(a) Interpretation of current scientific 

literature related to epidemiology, 

statistics, surveillance, Healthy People 

2030 objectives, and other public health 

issues; 

(b) Design and implementation of 

each program component such as 

surveillance, epidemiologic analysis, 

outbreak investigation, development of 

epidemiologic studies, development of 

disease control programs, and 

coordination of activities; and 

(c) Overall operational planning and 

program management. 

(2) Coordinate all IHS epidemiologic 

activities on a national scope including 

development and management of 

disease surveillance systems, generation 

of related reports, and investigation of 

disease outbreaks. 

(3) Conduct routine site visits to TECs 

and/or coordinate TEC visits to IHS to 

assess work plans and ensure data 

security; confirm compliance with 

applicable laws and regulations; assess 

program activities; and to mutually 

resolve problems, as needed. 

(4) Participate in annual TEC meeting 

for information sharing, problem 

solving, or training. 

(5) Provide training in the use of data 

from the Epidemiology Data Mart (EDM) 

and other IHS systems for the purposes 

of creating reports for disease 

surveillance, epidemiologic analysis, 

and epidemiologic studies. Training can 

be provided online or onsite, depending 

on staff availability. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41067 

(6) Coordinate opportunities for 

training of TEC staff where applicable. 

Examples include webinars on the EDM 

and data use, technical assistance, use 

of statistical software, and fellowship 

opportunities. 

III. Eligibility Information 

1. Eligibility 

To be eligible for this FY 2021 

funding opportunity applicants must: 

A. Be one of the following as defined 

by 25 U.S.C. 1603: 

1. A Federally-recognized Indian 

Tribe as defined by 25 U.S.C. 1603(14). 

The term ‘‘Indian Tribe’’ means any 

Indian Tribe, band, nation, or other 

organized group or community, 

including any Alaska Native village or 

group or regional or village corporation 

as defined in or established pursuant to 

the Alaska Native Claims Settlement Act 

(85 Stat. 688) [43 U.S.C. 1601 et seq.], 

which is recognized as eligible for the 

special programs and services provided 

by the U.S. to Indians because of their 

status as Indians. 

2. A Tribal organization as defined by 

25 U.S.C. 1603(26). The term ‘‘Tribal 

organization’’ has the meaning given the 

term in section 4 of the Indian SelfDetermination and Education 

Assistance Act (25 U.S.C. 5304): ‘‘Tribal 

organization’’ means the recognized 

governing body of any Indian Tribe; any 

legally established organization of 

Indians which is controlled, sanctioned, 

or chartered by such governing body or 

which is democratically elected by the 

adult members of the Indian community 

to be served by such organization and 

which includes the maximum 

participation of Indians in all phases of 

its activities: Provided that, in any case 

where a contract is let or grant made to 

an organization to perform services 

benefiting more than one Indian Tribe, 

the approval of each such Indian Tribe 

shall be a prerequisite to the letting or 

making of such contract or grant. 

Applicant shall submit letters of support 

and/or Tribal Resolutions from the 

Tribes to be served. 

3. An Intertribal Consortium or Indian 

organization as defined by 25 U.S.C. 

1621m(d)(2) as: (A) Incorporated for the 

primary purpose of improving Indian 

health; and (B) representative of the 

Indian Tribes or Urban Indian 

communities residing in the area in 

which the Intertribal consortium is 

located. 

B. Demonstrate that they have 

complied with previous terms and 

conditions of the Epidemiology Program 

for AI/AN Tribes and Urban Indian 

Communities grant in order to receive 

funding under this announcement; and 

C. Represent or serve a population of 

at least 60,000 AI/AN people or 70 

percent of the Tribal governments in the 

Area to be eligible, as demonstrated by 

Tribal Resolutions, blanket Tribal 

Resolutions, Tribal Letters of Support 

(LoS) or LoS from Urban Indian clinic 

directors and/or Chief Executive 

Officers (CEOs). Applicants must 

describe the population of AI/AN 

people and Tribes that will be 

represented. The number of AI/AN 

people served must be substantiated by 

documentation describing IHS user 

populations, U.S. Census Bureau data, 

clinical catchment data, or any method 

that is scientifically and 

epidemiologically valid. Resolutions or 

LoS from each Tribe, AN village and 

LoS from each Urban Indian community 

represented must be included in the 

application package. Resolutions or LoS 

must be current (e.g., not pre-date 

inception of the applicant epidemiology 

center) and express explicit support for 

the applicant epidemiology center. 

Collaborations with IHS Areas, Federal 

agencies such as the CDC, state, 

academic institutions, or other 

organizations are encouraged (letters of 

support and collaboration should be 

included in the application). If 

applicants do not have 100 percent 

Tribal support for their work, applicants 

must report the proportion and 

estimated population of the Tribes in 

their Area that do not support their 

work explicitly through LoS or 

resolution. 

The DEDP will notify any applicants 

deemed ineligible. 

Note: Please refer to Section IV.2 

(Application and Submission 

Information/Subsection 2, Content and 

Form of Application Submission) for 

additional proof of applicant status 

documents required, such as Tribal 

Resolutions, proof of non-profit status, 

etc. 

2. Cost Sharing or Matching 

The IHS does not require matching 

funds or cost sharing for grants or 

cooperative agreements. 

3. Other Requirements 

Applications with budget requests 

that exceed the highest dollar amount 

outlined under Section II Award 

Information, Estimated Funds Available, 

or exceed the Period of Performance 

outlined under Section II Award 

Information, Period of Performance will 

be considered not responsive and will 

not be reviewed. The Division of Grants 

Management (DGM) will notify the 

applicant. 

Tribal Resolution 

The DGM must receive an official, 

signed Tribal Resolution prior to issuing 

a Notice of Award (NoA) to any 

applicant selected for funding. An 

Indian Tribe or Tribal organization that 

is proposing a project affecting another 

Indian Tribe must include resolutions 

from all affected Tribes to be served. 

However, if an official, signed Tribal 

Resolution cannot be submitted with the 

application prior to the application 

deadline date, a draft Tribal Resolution 

must be submitted with the application 

by the deadline date in order for the 

application to be considered complete 

and eligible for review. The draft Tribal 

Resolution is not in lieu of the required 

signed resolution, but is acceptable until 

a signed resolution is received. If an 

application without a signed Tribal 

Resolution is selected for funding, the 

applicant will be contacted by the 

Grants Management Specialist (GMS) 

listed in this funding announcement 

and given 90 days to submit an official, 

signed Tribal Resolution to the GMS. If 

the signed Tribal Resolution is not 

received within 90 days, the award will 

be forfeited. 

Tribes organized with a governing 

structure other than a Tribal council 

may submit an equivalent document 

commensurate with their governing 

organization. 

IV. Application and Submission 

Information 

1. Obtaining Application Materials 

The application package and detailed 

instructions for this announcement are 

hosted on https://www.Grants.gov. 

Please direct questions regarding the 

application process to Mr. Paul Gettys at 

(301) 443–2114 or (301) 443–5204. 

2. Content and Form Application 

Submission 

The applicant must include the 

project narrative as an attachment to the 

application package. Mandatory 

documents for all applicants include: 

• Abstract (one page) summarizing 

the project. 

• Application forms: 

1. SF–424, Application for Federal 

Assistance. 

2. SF–424A, Budget Information— 

Non-Construction Programs. 

3. SF–424B, Assurances—NonConstruction Programs. 

• Project Narrative (not to exceed 12 

pages). See Section IV.2.A Project 

Narrative for instructions. 

1. Background information on the 

organization. 

2. Proposed scope of work, objectives, 

and activities that provide a description 


lotter on DSK11XQN23PROD with NOTICES1
41068 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

of what the applicant plans to 

accomplish. 

• Proposed logic model. 

• Budget Justification and Narrative 

(not to exceed five pages). See Section 

IV.2.B Budget Narrative for instructions. 

• One-page Timeframe Chart. 

• Tribal Resolution(s) or Letters of 

Support. 

• Letters of Support from 

organization’s Board of Directors. 

• 501(c)(3) Certificate, if applicable. 

• Biographical sketches for all Key 

Personnel. 

• Contractor/Consultant resumes or 

qualifications and scope of work. 

• Disclosure of Lobbying Activities 

(SF–LLL). 

• Certification Regarding Lobbying 

(GG-Lobbying Form). 

• Copy of current Negotiated Indirect 

Cost rate (IDC) agreement (required in 

order to receive IDC). 

• Organizational Chart (optional). 

• Documentation of current Office of 

Management and Budget (OMB) 

Financial Audit (if applicable). 

Acceptable forms of documentation 

include: 

1. Email confirmation from Federal 

Audit Clearinghouse (FAC) that audits 

were submitted; or 

2. Face sheets from audit reports. 

Applicants can find these on the FAC 

website at https://harvester.census.gov/ 

facdissem/Main.aspx. 

Public Policy Requirements 

All Federal public policies apply to 

IHS grants and cooperative agreements. 

Pursuant to 45 CFR 80.3(d), an 

individual shall not be deemed 

subjected to discrimination by reason of 

their exclusion from benefits limited by 

Federal law to individuals eligible for 

benefits and services from the IHS. See 

https://www.hhs.gov/grants/grants/ 

grants-policies-regulations/index.html. 

Requirements for Project and Budget 

Narratives 

A. Project Narrative 

This narrative should be a separate 

document that is no more than 12 pages 

and must: (1) Have consecutively 

numbered pages; (2) use black font 12 

points or larger; (3) be single-spaced; (4) 

and be formatted to fit standard letter 

paper (81⁄2 x 11 inches). 

Be sure to succinctly answer all 

questions listed under the evaluation 

criteria (refer to Section V.1, Evaluation 

Criteria) and place all responses and 

required information in the correct 

section noted below or they will not be 

considered or scored. If the narrative 

exceeds the page limit, the application 

will be considered not responsive and 

will not be reviewed. The 12-page limit 

for the narrative does not include the 

work plan, standard forms, Tribal 

Resolutions or LoS, budget, budget 

justifications, narratives, and/or other 

items. 

There are three parts to the narrative: 

Part 1—Program Information; Part 2— 

Program Planning and Evaluation; and 

Part 3—Program Report. See below for 

additional details about what must be 

included in the narrative. 

The page limits below are for each 

narrative and budget submitted. 

Part 1: Program Information (Limit—3 

pages) 

Section 1: Introduction and Need for 

Assistance 

Must include the applicant’s 

background information, a description 

of epidemiological service, 

epidemiologic capacity, and history of 

support for such activities. Applicants 

need to include current public health 

activities, what program services are 

currently being provided, and 

interactions with other public health 

authorities in the region (state, local, or 

Tribal). 

Section 2: Organizational Capabilities 

The applicant must describe staff 

capabilities or hiring plans for the key 

personnel with appropriate expertise in 

epidemiology, health sciences, and 

program management. The applicant 

must also demonstrate access to 

specialized expertise such as a doctoral 

level epidemiologist and/or a 

biostatistician. Applicants must include 

an organizational chart and provide 

position descriptions and biographical 

sketches of key personnel including 

consultants or contractors. The position 

description should clearly describe each 

position and its duties. Resume should 

indicate that proposed staff is qualified 

to carry out the project activities. 

Section 3: User Population 

The number of AI/AN people served 

must be substantiated by documentation 

describing IHS user populations, U.S. 

Census Bureau data, clinical catchment 

data, or any method that is scientifically 

and epidemiologically valid. 

Part 2: Program Planning and Evaluation 

(Limit—5 pages) 

Section 1: Program Plans 

Applicant must include a work plan 

that describes program goals, objectives, 

activities, timeline, and responsible 

person for carrying out the objectives/ 

activities. The applicant must include at 

least a minimum of four of the seven 

core functions of the IHCIA and other 

activities listed under the Required, 

Optional, and Allowable Activities. 

Section 2: Program Evaluation 

Applicant must define the criteria to 

be used to evaluate activities listed in 

the work plan under the Grantee 

Cooperative Agreement Award 

Activities. Criteria must include the 

collection, management, and reporting 

of established TEC IHS GPRA measures. 

They must explain the methodology that 

will be used to determine if the needs 

identified for the objectives are being 

met and if the outcomes identified are 

being achieved and describe how 

evaluation findings will be 

disseminated to the IHS, co-funders, 

and the population served. The 

evaluation plan must include a logic 

model (not counted in the page limit) 

with at least one measurable outcome 

per required activity. Applicants are 

strongly encouraged to base their logic 

model on the Draft Logic Model 

supplied with this notice. 

Part 3: Program Report (Limit—4 pages) 

Section 1: Describe Major 

Accomplishments Over the Last 24 

Months 

Please identify and describe 

significant program achievements 

associated with the delivery of quality 

health services. Provide a comparison of 

the actual accomplishments to the goals 

established for the project period or, if 

applicable, provide justification for the 

lack of progress. 

Section 2: Describe Major Activities 

Over the Last 24 Months 

Please identify and summarize recent, 

major project activities related to the 

work proposed in the last 24 months. 

Section 3: Describe Epidemiology 

Activities Over the Last 5 Years 

Please identify and summarize 

substantial epidemiology center 

activities conducted over the last five 

years, especially those you propose to 

continue. 

B. Budget Narrative (Limit—5 pages) 

Provide a budget narrative that 

explains the amounts requested for each 

line item of the budget from the SF– 

424A (Budget Information for NonConstruction Programs). The budget 

narrative should specifically describe 

how each item will support the 

achievement of proposed objectives. Be 

very careful about showing how each 

item in the ‘‘Other’’ category is justified. 

For subsequent budget years (see MultiYear Project Requirements in Section 

V.1. Application Review Information, 

Evaluation Criteria), the narrative 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41069 

should highlight the changes from year 

1 or clearly indicate that there are no 

substantive budget changes during the 

period of performance. Do NOT use the 

budget narrative to expand the project 

narrative. 

3. Submission Dates and Times 

Applications must be submitted 

through Grants.gov by 11:59 p.m. 

Eastern Time on the Application 

Deadline Date. Any application received 

after the application deadline will not 

be accepted for review. Grants.gov will 

notify the applicant via email if the 

application is rejected. 

If technical challenges arise and 

assistance is required with the 

application process, contact Grants.gov 

Customer Support (see contact 

information at https://www.grants.gov). 

If problems persist, contact Mr. Paul 

Gettys (Paul.Gettys@ihs.gov), Acting 

Director, DGM, by telephone at (301) 

443–2114 or (301) 443–5204. Please be 

sure to contact Mr. Gettys at least ten 

days prior to the application deadline. 

Please do not contact the DGM until you 

have received a Grants.gov tracking 

number. In the event you are not able 

to obtain a tracking number, call the 

DGM as soon as possible. 

IHS will not acknowledge receipt of 

applications. 

4. Intergovernmental Review 

Executive Order 12372 requiring 

intergovernmental review is not 

applicable to this program. 

5. Funding Restrictions 

• Pre-award costs are allowable up to 

90 days before the start date of the 

award provided the costs are otherwise 

allowable if awarded. Pre-award costs 

are incurred at the risk of the applicant. 

• The available funds are inclusive of 

direct and indirect costs. 

• Only one cooperative agreement 

will be awarded per applicant. 

6. Electronic Submission Requirements 

All applications must be submitted 

via Grants.gov. Please use the https://

www.Grants.gov website to submit an 

application. Find the application by 

selecting the ‘‘Search Grants’’ link on 

the homepage. Follow the instructions 

for submitting an application under the 

Package tab. No other method of 

application submission is acceptable. 

If the applicant cannot submit an 

application through Grants.gov, a 

waiver must be requested. Prior 

approval must be requested and 

obtained from Mr. Paul Gettys, Acting 

Director, DGM. A written waiver request 

must be sent to GrantsPolicy@ihs.gov 

with a copy to Paul.Gettys@ihs.gov. The 

waiver request must: (1) Be documented 

in writing (emails are acceptable) before 

submitting an application by some other 

method, and (2) include clear 

justification for the need to deviate from 

the required application submission 

process. 

Once the waiver request has been 

approved, the applicant will receive a 

confirmation of approval email 

containing submission instructions. A 

copy of the written approval must be 

included with the application that is 

submitted to the DGM. Applications 

that are submitted without a copy of the 

signed waiver from the Acting Director 

of the DGM will not be reviewed. The 

Grants Management Officer of the DGM 

will notify the applicant via email of 

this decision. Applications submitted 

under waiver must be received by the 

DGM no later than 5:00 p.m., Eastern 

Time, on the Application Deadline Date. 

Late applications will not be accepted 

for processing. Applicants that do not 

register for both the System for Award 

Management (SAM) and Grants.gov 

and/or fail to request timely assistance 

with technical issues will not be 

considered for a waiver to submit an 

application via alternative method. 

Please be aware of the following: 

• Please search for the application 

package in https://www.Grants.gov by 

entering the Assistance Listing (CFDA) 

number or the Funding Opportunity 

Number. Both numbers are located in 

the header of this announcement. 

• If you experience technical 

challenges while submitting your 

application, please contact Grants.gov 

Customer Support (see contact 

information at https://www.grants.gov). 

• Upon contacting Grants.gov, obtain 

a tracking number as proof of contact. 

The tracking number is helpful if there 

are technical issues that cannot be 

resolved and a waiver from the agency 

must be obtained. 

• Applicants are strongly encouraged 

not to wait until the deadline date to 

begin the application process through 

Grants.gov as the registration process for 

SAM and Grants.gov could take up to 20 

working days. 

• Please follow the instructions on 

Grants.gov to include additional 

documentation that may be requested by 

this funding announcement. 

• Applicants must comply with any 

page limits described in this funding 

announcement. 

• After submitting the application, 

the applicant will receive an automatic 

acknowledgment from Grants.gov that 

contains a Grants.gov tracking number. 

The IHS will not notify the applicant 

that the application has been received. 

Dun and Bradstreet (D&B) Data 

Universal Numbering System (DUNS) 

Applicants and grantee organizations 

are required to obtain a DUNS number 

and maintain an active registration in 

the SAM database. The DUNS number 

is a unique 9-digit identification number 

provided by D&B that uniquely 

identifies each entity. The DUNS 

number is site specific; therefore, each 

distinct performance site may be 

assigned a DUNS number. Obtaining a 

DUNS number is easy, and there is no 

charge. To obtain a DUNS number, 

please access the request service 

through https://fedgov.dnb.com/ 

webform, or call (866) 705–5711. 

The Federal Funding Accountability 

and Transparency Act of 2006, as 

amended (‘‘Transparency Act’’), 

requires all HHS recipients to report 

information on sub-awards. 

Accordingly, all IHS grantees must 

notify potential first-tier sub-recipients 

that no entity may receive a first-tier 

sub-award unless the entity has 

provided its DUNS number to the prime 

grantee organization. This requirement 

ensures the use of a universal identifier 

to enhance the quality of information 

available to the public pursuant to the 

Transparency Act. 

System for Award Management (SAM) 

Organizations that are not registered 

with SAM must have a DUNS number 

first, then access the SAM online 

registration through the SAM home page 

at https://www.sam.gov/SAM/ (U.S. 

organizations will also need to provide 

an Employer Identification Number 

from the Internal Revenue Service that 

may take an additional 2–5 weeks to 

become active). Please see SAM.gov for 

details on the registration process and 

timeline. Registration with the SAM is 

free of charge, but can take several 

weeks to process. Applicants may 

register online at https://www.sam.gov/ 

SAM/. 

Additional information on 

implementing the Transparency Act, 

including the specific requirements for 

DUNS and SAM, are available on the 

DGM Grants Management, Policy Topics 

web page: https://www.ihs.gov/dgm/ 

policytopics/. 

V. Application Review Information 

Possible points assigned to each 

section are noted in parentheses. The 

12-page project narrative should include 

only the first year of activities; 

information for multi-year projects 

should be included as an appendix. See 

‘‘Multi-year Project Requirements’’ at 

the end of this section for more 

information. The narrative section 


lotter on DSK11XQN23PROD with NOTICES1
41070 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

should be written in a manner that is 

clear to outside reviewers unfamiliar 

with prior related activities of the 

applicant. It should be well organized, 

succinct, and contain all information 

necessary for reviewers to understand 

the project fully. Points will be assigned 

to each evaluation criteria adding up to 

a total of 100 possible points. Points are 

assigned as follows: 

1. Evaluation Criteria 

The instructions for preparing the 

application narrative also constitute the 

evaluation criteria for reviewing and 

scoring the application. Points are 

assigned as follows: 

A. Introduction and Need for Assistance 

(10 points) 

a. Describe the applicant’s current 

public health activities including 

programs or services currently provided, 

interactions with other public health 

authorities in the regions (state, local, or 

Tribal) and how long it has been 

operating. Specifically describe current 

epidemiologic capacity and history of 

support for such activities. 

b. Provide a physical location of the 

TEC and area to be served by the 

proposed program, including a map 

(include the map in the attachments) 

and specifically describe the office 

space and how it is going to be paid for. 

c. Describe the applicant’s user 

population. The applicant must 

demonstrate AI/AN people will be 

served and must be substantiated by 

using documentation describing IHS 

user populations, U.S. Census Bureau 

data, clinical catchment data, or any 

method that is scientifically and 

epidemiologically valid data. 

B. Project Objectives, Work Plan, and 

Approach (35 points) 

a. State in measurable and realistic 

terms the objectives and appropriate 

activities to achieve each objective for 

the projects as listed in the Required, 

Optional, and Allowable Activities. The 

work plan needs to include the grantees 

desired objectives and must 

demonstrate a minimum of four of the 

seven TEC core functional areas as 

outlined in the IHCIA. 

b. Identify the expected results, 

benefits, and outcomes or products to be 

derived from each objective of the 

project. 

c. Include a work plan for each 

objective that indicates when the 

objectives and major activities will be 

accomplished and who will conduct the 

activities. 

C. Program Evaluation (10 points) 

a. Define the criteria to be used to 

evaluate activities listed in the work 

plan under the Required, Optional, and 

Allowable Activities. 

b. Explain the methodology that will 

be used to determine if the needs 

identified for the objectives are being 

met and if the outcomes identified are 

being achieved. Be explicit about how 

the logic model relates to the objectives 

and activities. Include the logic model 

in the appendix. 

c. Explain how the organization will 

participate in cross-organization 

evaluation activities, as needed. 

d. Describe how evaluation findings 

will be disseminated to stakeholders. 

D. Organizational Capabilities, Key 

Personnel, and Qualifications (10 

points) 

a. Explain both the management and 

administrative structure of the 

organization, including documentation 

of current certified financial 

management systems from the Bureau of 

Indian Affairs, IHS, or a Certified Public 

Accountant and an updated 

organizational chart (include in 

appendix). 

b. Describe the ability of the 

organization to manage a program of the 

proposed scope. 

c. Provide position descriptions and 

biographical sketches of Key Personnel, 

including those of consultants or 

contractors in the Other Attachments 

form in Grants.gov. Position 

descriptions should very clearly 

describe each position and its duties, 

indicating desired qualification and 

experience requirements related to the 

project. Resumes should indicate that 

the proposed staff is qualified to carry 

out the project activities. Applicants 

with expertise in epidemiology will 

receive priority. 

d. Applicant must at least have two 

epidemiologists as part of the proposal. 

E. Epidemiology Center Capacity (30 

points) 

a. Applicant must demonstrate 

current capacity and successes over 

time (five years) in providing 

epidemiology center services to Tribes 

and Tribal populations in their area. 

F. Categorical Budget and Budget 

Justification (5 points) 

a. The five points for Categorical 

Budget only applies to Year 1. Provide 

a line item budget and budget narrative 

for Year 1. 

b. Provide a justification by line item 

in the budget including sufficient cost 

and other details to facilitate the 

determination of cost allowance and 

relevance of these costs to the proposed 

project. The funds requested should be 

appropriate and necessary for the scope 

of the project. Be aware of and 

incorporate budget limits and 

requirements listed in the Required, 

Optional, and Allowable Activities in 

Section I. 

i. IHS recommends that applicants 

review https://www.ihs.gov/dper/ 

evaluation/evaluation-policy/ and plan 

their budget proposals in compliance 

with the general Evaluation Policy of 

IHS. 

c. If use of consultants or contractors 

are proposed or anticipated, provide a 

detailed budget and scope of work that 

clearly defines the deliverables or 

outcomes anticipated. 

d. If the applicant will be hosting a 

conference, the applicant must include 

a separate detailed budget justification 

and narrative for the conference. The 

cost categories to be addressed are as 

follows: (1) Contract/Planner, (2) 

Meeting Space/Venue, (3) Registration 

website, (4) Audio Visual, (5) Speakers 

Fees, (6) Non-Federal Attendee Travel, 

(7) Registration Fees, and (8) Other 

(explain in detail and cost breakdown). 

e. Applicant is required to submit a 

line item budget and budget narrative by 

category for years 2–5 as an appendix to 

show the five-year plan of the proposal. 

Multi-Year Project Requirements 

Applications must include a brief 

project narrative and budget (one 

additional page per year) addressing the 

developmental plans for each additional 

year of the project. This attachment will 

not count as part of the project narrative 

or the budget narrative. 

Additional documents can be 

uploaded as Appendix Items in 

Grants.gov. 

• Work plan, logic model, and/or 

timeline for proposed objectives. 

• Position descriptions for key staff. 

• Resumes of key staff that reflect 

current duties. 

• Consultant or contractor proposed 

scope of work and letter of commitment 

(if applicable). 

• Current Indirect Cost Rate 

Agreement. 

• Organizational chart. 

• Map of area identifying project 

location(s). 

• Logic model. 

• Additional documents to support 

narrative (i.e., data tables, key news 

articles, etc.). 

2. Review and Selection 

Each application will be prescreened 

for eligibility and completeness as 

outlined in the funding announcement. 

Applications that meet the eligibility 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41071 

criteria shall be reviewed for merit by 

the Objective Review Committee (ORC) 

based on evaluation criteria. Incomplete 

applications and applications that are 

not responsive to the administrative 

thresholds (budget limit, project period 

limit) will not be referred to the ORC 

and will not be funded. The applicant 

will be notified of this determination. 

Applicants must address all program 

requirements and provide all required 

documentation. 

3. Notifications of Disposition 

All applicants will receive an 

Executive Summary Statement from the 

IHS Office of Public Health Support 

within 30 days of the conclusion of the 

ORC outlining the strengths and 

weaknesses of their application. The 

summary statement will be sent to the 

Authorizing Official identified on the 

face page (SF–424) of the application. 

A. Award Notices for Funded 

Applications 

The NoA is the authorizing document 

for which funds are dispersed to the 

approved entities and reflects the 

amount of Federal funds awarded, the 

purpose of the grant, the terms and 

conditions of the award, the effective 

date of the award, and the budget/ 

project period. Each entity approved for 

funding must have a user account in 

GrantSolutions in order to retrieve the 

NoA. Please see the Agency Contacts list 

in Section VII for the systems contact 

information. 

B. Approved but Unfunded 

Applications 

Approved applications not funded 

due to lack of available funds will be 

held for one year. If funding becomes 

available during the course of the year, 

the application may be reconsidered. 

Note: Any correspondence other than 

the official NoA executed by an IHS 

grants management official announcing 

to the project director that an award has 

been made to their organization is not 

an authorization to implement their 

program on behalf of the IHS. 

VI. Award Administration Information 

1. Administrative Requirements 

Cooperative agreements are 

administered in accordance with the 

following regulations and policies: 

A. The criteria as outlined in this 

program announcement. 

B. Administrative Regulations for 

Grants: 

• Uniform Administrative 

Requirements, Cost Principles, and 

Audit Requirements for HHS Awards 

currently in effect or implemented 

during the period of award, other 

Department regulations and policies in 

effect at the time of award, and 

applicable statutory provisions. At the 

time of publication, this includes 45 

CFR part 75, at https://www.govinfo.gov/ 

content/pkg/CFR-2020-title45-vol1/pdf/ 

CFR-2020-title45-vol1-part75.pdf. 

• Please review all HHS regulatory 

provisions for Termination at 45 CFR 

75.372, at https://www.ecfr.gov/cgi-bin/ 

retrieveECFR?gp&

SID=2970eec67399fab1413ede5

3d7895d99&mc=true&n=pt

45.1.75&r=PART&ty=HTML

&se45.1.75_1372#se45.1.75_1372. 

C. Grants Policy: 

• HHS Grants Policy Statement, 

Revised 01/07, at http://www.hhs.gov/ 

sites/default/files/grants/grants/ 

policies-regulations/hhsgps107.pdf. 

D. Cost Principles: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Cost 

Principles,’’ at 45 CFR part 75, subpart 

E. 

E. Audit Requirements: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Audit 

Requirements,’’ at 45 CFR part 75, 

subpart F. 

F. As of August 13, 2020, 2 CFR 200 

has been updated to include a 

prohibition on certain 

telecommunications and video 

surveillance services or equipment. This 

prohibition is described in 2 CFR 

200.216. This will also be described in 

the terms and conditions of every IHS 

grant and cooperative agreement 

awarded on or after August 13, 2020. 

2. Indirect Costs 

This section applies to all recipients 

that request reimbursement of indirect 

costs (IDC) in their application budget. 

In accordance with HHS Grants Policy 

Statement, Part II–27, IHS requires 

applicants to obtain a current IDC rate 

agreement and submit it to the DGM 

prior to the DGM issuing an award. The 

rate agreement must be prepared in 

accordance with the applicable cost 

principles and guidance as provided by 

the cognizant agency or office. A current 

rate covers the applicable grant 

activities under the current award’s 

budget period. If the current rate 

agreement is not on file with the DGM 

at the time of award, the IDC portion of 

the budget will be restricted. The 

restrictions remain in place until the 

current rate agreement is provided to 

the DGM. 

Per 45 CFR 75.414(f) Indirect (F&A) 

costs, ‘‘any non-Federal entity [i.e., 

applicant] that has never received a 

negotiated indirect cost rate, . . . may 

elect to charge a de minimis rate of 10 

percent of modified total direct costs 

(MTDC) which may be used 

indefinitely. As described in Section 

75.403, costs must be consistently 

charged as either indirect or direct costs, 

but may not be double charged or 

inconsistently charged as both. If 

chosen, this methodology once elected 

must be used consistently for all Federal 

awards until such time as the nonFederal entity chooses to negotiate for a 

rate, which the non-Federal entity may 

apply to do at any time.’’ 

Electing to charge a de minimis rate 

of 10 percent only applies to applicants 

that have never received an approved 

negotiated indirect cost rate from HHS 

or another cognizant federal agency. 

Applicants awaiting approval of their 

indirect cost proposal may request the 

10 percent de minimis rate. When the 

applicant chooses this method, costs 

included in the indirect cost pool must 

not be charged as direct costs to the 

grant. 

Available funds are inclusive of direct 

and appropriate indirect costs. 

Approved indirect funds are awarded as 

part of the award amount, and no 

additional funds will be provided. 

Generally, IDC rates for IHS grantees 

are negotiated with the Division of Cost 

Allocation (DCA) at https://

rates.psc.gov/ or the Department of the 

Interior (Interior Business Center) at 

https://ibc.doi.gov/ICS/tribal. For 

questions regarding the indirect cost 

policy, please call the GMS listed under 

‘‘Agency Contacts’’ or the main DGM 

office at (301) 443–5204. 

3. Reporting Requirements 

The grantee must submit required 

reports consistent with the applicable 

deadlines. Failure to submit required 

reports within the time allowed may 

result in suspension or termination of 

an active grant, withholding of 

additional awards for the project, or 

other enforcement actions such as 

withholding of payments or converting 

to the reimbursement method of 

payment. Continued failure to submit 

required reports may result in the 

imposition of special award provisions, 

and/or the non-funding or non-award of 

other eligible projects or activities. This 

requirement applies whether the 

delinquency is attributable to the failure 

of the awardee organization or the 

individual responsible for preparation 

of the reports. Per DGM policy, all 

reports must be submitted electronically 

by attaching them as a ‘‘Grant Note’’ in 

GrantSolutions. Personnel responsible 

for submitting reports will be required 

to obtain a login and password for 

GrantSolutions. Please see the Agency 

Contacts list in Section VII for the 

systems contact information. 


lotter on DSK11XQN23PROD with NOTICES1
41072 Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 

The reporting requirements for this 

program are noted below. 

A. Progress Reports

Program progress reports are required

semi-annually. The progress reports are 

due within 30 days after the reporting 

period ends (specific dates will be listed 

in the NoA Terms and Conditions). 

These reports must include a brief 

comparison of actual accomplishments 

to the goals established for the period, 

a summary of progress to date or, if 

applicable, provide sound justification 

for the lack of progress, and other 

pertinent information as required. A 

final report must be submitted within 90 

days of expiration of the period of 

performance. 

B. Financial Reports

Federal Cash Transaction Reports are

due 30 days after the close of every 

calendar quarter to the Payment 

Management Services at https://

pms.psc.gov. Failure to submit timely 

reports may result in adverse award 

actions blocking access to funds. 

Federal Financial Reports are due 30 

days after the end of each budget period, 

and a final report is due 90 days after 

the end of the Period of Performance. 

Grantees are responsible and 

accountable for reporting accurate 

information on all required reports: The 

Progress Reports, the Federal Cash 

Transaction Report, and the Federal 

Financial Report. 

C. Data Collection and Reporting

Based on the required activities in

Section II, describe how grantee plans to 

collect data for the proposed project and 

activities. Identify any type(s) of 

evaluation(s) that will be used and how 

you will collaborate with partners to 

complete any evaluation efforts or data 

collection. Progress reports will include 

compilation of quantitative data (e.g., 

number served; screenings completed) 

and qualitative or narrative (text) data. 

Reporting elements should be specific to 

activities/programs, processes, and 

outcomes such as performance measures 

and other data relevant to evaluation 

outcomes, including intended results 

(i.e., impact and outcomes). Grantees 

will be required to collect and submit 

responses to specific data calls upon 

request, as well as semi-annual and 

annual progress reports. 

D. Post Conference Grant Reporting

The following requirements were

enacted in Section 3003 of the 

Consolidated Continuing 

Appropriations Act, 2013, Public Law 

113–6, 127 Stat. 198, 435 (2013), and; 

Office of Management and Budget 

Memorandum M–17–08, Amending 

OMB Memorandum M–12–12: All HHS/ 

IHS awards containing grants funds 

allocated for conferences will be 

required to complete a mandatory post 

award report for all conferences. 

Specifically: The total amount of funds 

provided in this award/cooperative 

agreement that were spent for 

‘‘Conference X,’’ must be reported in 

final detailed actual costs within 15 

calendar days of the completion of the 

conference. Cost categories to address 

should be: (1) Contract/Planner, (2) 

Meeting Space/Venue, (3) Registration 

website, (4) Audio Visual, (5) Speakers 

Fees, (6) Non-Federal Attendee Travel, 

(7) Registration Fees, and (8) Other.

E. Federal Sub-Award Reporting System

(FSRS)

This award may be subject to the 

Transparency Act sub-award and 

executive compensation reporting 

requirements of 2 CFR part 1 70. 

The Transparency Act requires the 

OMB to establish a single searchable 

database, accessible to the public, with 

information on financial assistance 

awards made by Federal agencies. The 

Transparency Act also includes a 

requirement for recipients of Federal 

grants to report information about firsttier sub-awards and executive 

compensation under Federal assistance 

awards. 

IHS has implemented a Term of 

Award into all IHS Standard Terms and 

Conditions, NoAs, and funding 

announcements regarding the FSRS 

reporting requirement. This IHS Term of 

Award is applicable to all IHS grant and 

cooperative agreements issued on or 

after October 1, 2010, with a $25,000 

sub-award obligation threshold met for 

any specific reporting period. 

For the full IHS award term 

implementing this requirement and 

additional award applicability 

information, visit the DGM Grants 

Management website at https://

www.ihs.gov/dgm/policytopics/. 

F. Compliance With Executive Order

13166 Implementation of Services

Accessibility Provisions for All Grant

Application Packages and Funding

Opportunity Announcements

Recipients of Federal financial 

assistance (FFA) from HHS must 

administer their programs in 

compliance with Federal civil rights 

laws that prohibit discrimination on the 

basis of race, color, national origin, 

disability, age and, in some 

circumstances, religion, conscience, and 

sex. This includes ensuring programs 

are accessible to persons with limited 

English proficiency. The HHS Office for 

Civil Rights provides guidance on 

complying with civil rights laws 

enforced by HHS. Please see https://

www.hhs.gov/civil-rights/for-providers/ 

provider-obligations/index.html and 

http://www.hhs.gov/ocr/civilrights/ 

understanding/section1557/index.html. 

• Recipients of FFA must ensure that

their programs are accessible to persons 

with limited English proficiency. HHS 

provides guidance to recipients of FFA 

on meeting their legal obligation to take 

reasonable steps to provide meaningful 

access to their programs by persons with 

limited English proficiency. Please see 

https://www.hhs.gov/civil-rights/forindividuals/special-topics/limitedenglish-proficiency/fact-sheet-guidance/ 

index.html and https://www.lep.gov. For 

further guidance on providing culturally 

and linguistically appropriate services, 

recipients should review the National 

Standards for Culturally and 

Linguistically Appropriate Services in 

Health and Health Care at https://

minorityhealth.hhs.gov/omh/ 

browse.aspx?lvl=2&lvlid=53. 

• Recipients of FFA also have specific

legal obligations for serving qualified 

individuals with disabilities. Please see 

http://www.hhs.gov/ocr/civilrights/

understanding/disability/index.html. 

• HHS funded health and education

programs must be administered in an 

environment free of sexual harassment. 

Please see https://www.hhs.gov/civilrights/for-individuals/sexdiscrimination/index.html; https://

www2.ed.gov/about/offices/list/ocr/ 

docs/shguide.html; and https://

www.eeoc.gov/eeoc/publications/fssex.cfm. 

• Recipients of FFA must also

administer their programs in 

compliance with applicable Federal 

religious nondiscrimination laws and 

applicable Federal conscience 

protection and associated antidiscrimination laws. Collectively, these 

laws prohibit exclusion, adverse 

treatment, coercion, or other 

discrimination against persons or 

entities on the basis of their 

consciences, religious beliefs, or moral 

convictions. Please see https://

www.hhs.gov/conscience/conscienceprotections/index.html and https://

www.hhs.gov/conscience/religiousfreedom/index.html. 

Please contact the HHS Office for 

Civil Rights for more information about 

obligations and prohibitions under 

Federal civil rights laws at https://

www.hhs.gov/ocr/about-us/contact-us/ 

index.html or call 1–800–368–1019 or 

TDD 1–800–537–7697. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices 41073 

G. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the Federal Awardee 

Performance and Integrity Information 

System (FAPIIS) at https://

www.fapiis.gov before making any 

award in excess of the simplified 

acquisition threshold (currently 

$250,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a Federal awarding agency 

previously entered. IHS will consider 

any comments by the applicant, in 

addition to other information in FAPIIS, 

in making a judgment about the 

applicant’s integrity, business ethics, 

and record of performance under 

Federal awards when completing the 

review of risk posed by applicants as 

described in 45 CFR 75.205. 

As required by 45 CFR part 75 

Appendix XII of the Uniform Guidance, 

non-Federal entities (NFEs) are required 

to disclose in FAPIIS any information 

about criminal, civil, and administrative 

proceedings, and/or affirm that there is 

no new information to provide. This 

applies to NFEs that receive Federal 

awards (currently active grants, 

cooperative agreements, and 

procurement contracts) greater than 

$10,000,000 for any period of time 

during the period of performance of an 

award/project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and the HHS 

implementing regulations at 45 CFR part 

75, the IHS must require a non-Federal 

entity or an applicant for a Federal 

award to disclose, in a timely manner, 

in writing to the IHS or pass-through 

entity all violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 

Submission is required for all 

applicants and recipients, in writing, to 

the IHS and to the HHS Office of 

Inspector General all information 

related to violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services, Indian Health Service, 

Division of Grants Management, ATTN: 

Paul Gettys, Acting Director, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line), Office: (301) 443–5204, 

Fax: (301) 594–0899, Email: 

Paul.Gettys@ihs.gov. 

And 

U.S. Department of Health and 

Human Services, Office of Inspector 

General, ATTN: Mandatory Grant 

Disclosures, Intake Coordinator, 330 

Independence Avenue SW, Cohen 

Building, Room 5527, Washington, DC 

20201, URL: https://oig.hhs.gov/fraud/ 

report-fraud/, (Include ‘‘Mandatory 

Grant Disclosures’’ in subject line), Fax: 

(202) 205–0604 (Include ‘‘Mandatory 

Grant Disclosures’’ in subject line) or, 

Email: MandatoryGranteeDisclosures@

oig.hhs.gov. 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371 Remedies 

for noncompliance, including 

suspension or debarment (See 2 CFR 

parts 180 & 376). 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Lisa C. Neel, 

MPH, Public Health Advisor, Indian 

Health Service, Office of Public Health 

Support, Division of Epidemiology & 

Disease Prevention, Indian Health 

Service, 5600 Fishers Lane, Mailstop 

09E10D, Rockville, MD 20857, Phone: 

(301) 443–4305, Email: lisa.neel@

ihs.gov. 

2. Questions on grants management 

and fiscal matters may be directed to: 

John Hoffman, Senior Grants 

Management Specialist, Indian Health 

Service, Division of Grants 

Management, 5600 Fishers Lane, 

Mailstop 09E70, Rockville, MD 20857, 

Phone: (301) 443–2116, Email: 

John.Hoffman@ihs.gov. 

3. Questions on systems matters may 

be directed to: Paul Gettys, Acting 

Director, Indian Health Service, 

Division of Grants Management, 5600 

Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, Phone: (301) 443– 

2114; or the DGM main line (301) 443– 

5204, E-Mail: Paul.Gettys@ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Elizabeth A. Fowler, 

Acting Director, Indian Health Service. 

[FR Doc. 2021–16281 Filed 7–29–21; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; Institutional 

Research Training Grants (IT). 

Date: August 24, 2021. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Complementary 

and Integrative, Democracy II, 6707 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Shiyong Huang, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, Division of Extramural Activities, 

NCCIH/NIH, 6707 Democracy Boulevard, 

Suite 401, Bethesda, MD 20817, 

shiyong.huang@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: July 26, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16261 Filed 7–29–21; 8:45 am] 

BILLING CODE 4140–01–P 


lotter on DSK11XQN23PROD with NOTICES1